Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Current Leases (2019 - 2025)

Historic Current Leases for Novartis Ag (NVSEF) over the last 7 years, with Q4 2025 value amounting to $1.7 billion.

  • Novartis Ag's Current Leases rose 567.6% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year increase of 567.6%. This contributed to the annual value of $1.7 billion for FY2025, which is 567.6% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Current Leases is $1.7 billion, which was up 567.6% from $1.6 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Current Leases ranged from a high of $1.7 billion in Q2 2021 and a low of $275.0 million during Q4 2021
  • In the last 5 years, Novartis Ag's Current Leases had a median value of $1.6 billion in 2022 and averaged $1.5 billion.
  • In the last 5 years, Novartis Ag's Current Leases crashed by 8400.23% in 2021 and then skyrocketed by 45927.27% in 2022.
  • Quarter analysis of 5 years shows Novartis Ag's Current Leases stood at $275.0 million in 2021, then soared by 459.27% to $1.5 billion in 2022, then grew by 3.9% to $1.6 billion in 2023, then fell by 1.88% to $1.6 billion in 2024, then increased by 5.68% to $1.7 billion in 2025.
  • Its last three reported values are $1.7 billion in Q4 2025, $1.6 billion for Q3 2025, and $1.6 billion during Q2 2025.